Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced that it has favorably amended a credit agreement with one of its term lenders, resulting in improved terms, and greater financial flexibility which aligns with the Company’s strategic focus on its expanding cannabis businesses internationally.

The Company announced that it has amended its Fresh Produce loan with Farm Credit Canada (“FCC Loan”) to improve financial covenants which will enable the Company to progress its business without continued waiver requirements. These changes reflect considerable expansion and growth of Village Farms’ business since entering into the original credit agreement in 2013, as well a recognition of the Company’s stronger strategic focus on its growing cannabis business. The FCC Loan carries a variable interest rate below 8.0 percent and matures on May 3, 2027. Other material terms for the FCC Loan remain unchanged.

Michael DeGiglio, Chief Executive Officer of Village Farms commented, “Today’s announcement reflects our long-standing, collaborative relationship with FCC and their continued support of our growth strategy. More favorable financial covenants on our FCC loan will enable us greater flexibility to make further growth investments in the future. We believe this amendment demonstrates strength in our business, which is positioned for a strong year of growth in 2025.”

About Village Farms International

Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods. The Company has a strong foundation as the leading and longest-tenured fresh produce supplier to grocery and large-format retailers throughout the US and Canada and is capitalizing on new high-growth opportunities in the cannabis and CBD categories in North America, the Netherlands and selected markets internationally.

The post Village Farms International, Inc. (VFF) Announces Favorable Amendment to FCC Credit Agreement appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

As the tariffs are set in place, it will probably create a ripple effect throughout the cannabis industry. This may impact things from production costs to market prices. Even how marijuana stocks trade, although the sector has been down for some time. As tariffs are implemented, import costs for materials needed in cannabis, such as hydroponic systems, lighting equipment, and other growing supplies, may increase.

This increase could lead to higher operational costs for cannabis farmers. Increased operation costs may put operators in a position to charge more for cannabis goods in response to the higher prices for cannabis products. From an investment perspective, top marijuana stocks may react poorly to these changes. Yet, investors are assessing the potential for a future turnaround in trading.

With how low the sector has been performing finding top Marijana stocks to buy at lower shares is still possible. The idea is to see what will come and hope to see a stronger industry and more success down the line. Which is the speculation many cannabis stock shareholders have. They are planning for the future as this is where they see the silver lining to all that is happening. The marijuana stocks to watch mentioned below could be a few options to consider during this time.

Marijuana Stocks To Watch In Volatile Sector

1. Green Thumb Industries Inc. (OTC:GTBIF)
2. Greenlane Holdings, Inc. (NASDAQ:GNLN)

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. 

In recent news, the company has announced it will hold a Q1 2025 earnings conference call. May 7th is the date that Green Thumb has selected for this call to take place.

[Read More] This Is How The Tariffs Will Impact Marijuana Stocks In 2025

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, and Europe. It operates in two segments, Consumer Goods and Industrial Goods.

At the end of March, the company announced it would join the Mainstem B2B procurement marketplace platform. MainStem offers an end-to-end, enterprise-level supply chain solution designed to streamline procurement for the legal cannabis industry.

[Read More] April 2025 Watchlist: Best Ancillary Cannabis Stocks for Growth Potential

Words From The Company

“At Greenlane, our strategy is to deliver quality, a diverse selection of cannabis and wellness products, and value for our customers,” said Barbara Sher, Chief Executive Officer for Greenlane.”

The post 2 Marijuana Stocks To Watch In An Uncertain Time appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to show impressive growth, making marijuana penny stocks a hot topic for investors this week. In 2024, legal cannabis sales reached over $32 billion across the country. That number is expected to grow past $50 billion by the end of 2025. Many states are expanding access to both medical and recreational marijuana, helping fuel this rapid expansion. In addition, recent discussions around federal reform have renewed optimism. There are growing calls to reschedule cannabis to reflect its medical use. If changes happen, they could unlock major opportunities in the market. Because of this momentum, many investors are turning their attention to low-cost marijuana stocks with high potential.

However, investing in penny stocks requires a disciplined and cautious approach. These stocks are highly volatile and can shift quickly in price. Using technical analysis can help identify strong setups and ideal trade entries. Traders commonly use indicators like moving averages and RSI. But it is equally important to manage risk with each trade. This means setting stop-loss levels, sticking to a budget, and avoiding oversized positions. It also helps to track industry news and price trends for early warning signs. Combined with a solid plan, technical tools, and risk control, it can make trading marijuana penny stocks more manageable.

Cannabis Stocks Making Headlines

As the U.S. cannabis industry grows in 2025, investors are keeping a close eye on several promising marijuana stocks. While federal legalization remains uncertain, many state markets continue to expand. This gives vertically integrated companies room to grow operations and gain market share. In April 2025, three U.S. cannabis companies stand out for their performance and presence—Ayr Wellness Inc. (AYRWF), Ascend Wellness Holdings (AAWH), and The Cannabist Company Holdings Inc. (CBSTF). Each company operates a growing retail network and is positioned to benefit from market developments. With improving balance sheets and disciplined growth strategies, they have become top names to watch this month.

[Read More] This Is How The Tariffs Will Impact Marijuana Stocks In 2025

Top U.S. Marijuana Stocks to Watch Right Now for Growth Potential

1. Ayr Wellness Inc. (OTC: AYRWF)
2. Ascend Wellness Holdings (OTC: AAWH)
3. The Cannabist Company Holdings Inc. (OTC: CBSTF)

Ayr Wellness Inc. (AYRWF)

Ayr Wellness is a vertically integrated cannabis operator with a strong presence in multiple U.S. markets. The company’s largest footprint is in Florida, where it operates 67 dispensaries across the state. Ayr is also active in states like Pennsylvania, Ohio, and Connecticut, giving it a diverse presence. The company serves both medical and adult-use cannabis markets, focusing on premium products and in-house cultivation. Over the past year, Ayr has worked to strengthen its operations by closing underperforming stores and focusing on higher-margin assets. Its goal is to increase efficiency and return to consistent profitability. The company’s brand portfolio includes offerings across several categories, from edibles to concentrates.

In its most recent earnings report, Ayr posted quarterly revenue of $114 million. The company’s gross margin was 49%, showing improved operational efficiency. Adjusted EBITDA reached $19.1 million, marking a stable performance in a competitive market. Ayr also reported $10 million in cash flow from operations, which supports its efforts to reduce debt. The company ended the period with $35 million in cash, offering some financial flexibility. Despite continued industry headwinds, management is focused on sustainable growth and cost control. If markets stabilize, Ayr could see further upside from its streamlined operations and broad state footprint.

[Read More] April 2025 Watchlist: Leading Cannabis Stocks from Canada

Ascend Wellness Holdings (AAWH)

Ascend Wellness is another vertically integrated cannabis operator with a strong retail and wholesale presence. The company’s largest operations are in Illinois and Michigan, two of the most active cannabis markets in the Midwest. Ascend operates 36 dispensaries and continues to add locations in high-demand areas. It also maintains cultivation and production facilities to support its branded product lines. The company targets both recreational and medical consumers, with a focus on premium products. Ascend has steadily grown its market share by entering limited-license states and acquiring assets in key regions. Its strategy is based on disciplined expansion and operational efficiency.

Ascend recently reported full-year revenue of $561.6 million, showing solid year-over-year growth. Gross profit reached $184.2 million, with a gross margin of nearly 33%. Adjusted EBITDA came in at $116 million, reflecting a healthy 9% annual gain. The company ended the year with $88 million in cash, giving it a strong balance sheet. This cash position allows for continued expansion and potential debt reduction. Ascend has focused on streamlining operations and improving store-level profitability. Despite regulatory delays and margin pressure across the sector, it continues to show resilience. Investors may see more upside as the company refines operations and expands its store base.

[Read More] April 2025 Watchlist: Best Ancillary Cannabis Stocks for Growth Potential

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company, formerly known as Columbia Care, is one of the oldest licensed cannabis operators in the U.S. It has a wide national footprint, holding licenses in 14 states. The company operates 70 dispensaries and runs 19 cultivation and processing facilities. Its largest markets include New York, Virginia, and Florida. The Cannabist brand focuses on both medical and adult-use customers, offering products across all major cannabis categories. The company has spent the past year rebranding, improving customer experience, and divesting non-core assets. These moves are designed to improve profitability and focus on high-performing markets.

The Cannabist Company recently reported revenue of $114.8 million for the quarter, slightly down from previous levels. However, gross profit rose to $43.8 million, reflecting better cost controls. The company narrowed its net loss to just $1.8 million, showing significant improvement from prior quarters. Over the last few months, it sold non-core assets and raised $105 million, which improved its cash position. The company ended the quarter with $31.5 million in cash and plans to continue optimizing its portfolio. Management remains focused on reducing debt, improving margins, and expanding in high-growth states. With a leaner and more focused structure, The Cannabist Company is rebuilding investor confidence.

U.S. Cannabis Stocks Poised for Growth in the Current Market Cycle

Each of these three companies—Ayr Wellness, Ascend Wellness, and The Cannabist Company—has navigated the cannabis market’s recent volatility with discipline. While challenges remain, their large footprints, improving margins, and strategic cost reductions make them worth watching in April 2025. Investors looking for growth opportunities in U.S. cannabis may find value in these names as the industry begins its next phase of expansion.

The post Marijuana Stocks in Focus: U.S. Companies Ready for a Breakout appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The legal operators are now facing the reality of how Donald Trump’s tariffs will impact the cannabis industry. For the ancillary side of the cannabis industry, many products are made overseas. Places like China are deep into the cannabis industry. Some of the companies are known for manufacturing vaporizer parts and packaging solutions. Now with tariffs in place things that were once more affordable for cannabis consumers will ultimately go up in price.

However, how will this long-term impact legal operators as a business? Will the increase in goods hurt the market or lead to more profits? Are those who use cannabis going to look for cheaper products that fit their means and their budget? This is only the start as there is more to see. Another question is how will affect the public sector. Are the tariffs going to drop marijuana stocks further or will they bring in much-needed momentum?

At this time there are many unknowns as speculation on how to invest in cannabis stocks is still met with uncertainty. Some feel finding top marijuana stocks to buy now with how low the shares are is a good strategy for future gains. Especially with all that is going on across most niches in the public sector. Now is a good time to learn and keep an eye out for the best marijuana stocks to watch.

Top Marijuana Stocks To Follow In 2025

1. Glass House Brands Inc. (OTC:GLASF)
2. Planet 13 Holdings Inc. (OTC:PLNH)
3. FLUENT Corp. (OTC:CNTMF)

Glass House Brands Inc.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

Recently, the company announced a collaboration with the University of California, Berkeley, to explore hemp-related research. This includes novel medicinal product development, identification, and improvement of hemp genetics. As well as market analysis, supply chain sustainability, and AI automation for cultivation and production.

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

On April 2nd the company announced the opening of a new dispensary in Orange Park, FL. This new location not only expands its operations but it helps to better serve the medical cannabis community in Jacksonville.

Words From The Company

“We’re thrilled to open another convenient Planet 13 dispensary, bringing our award-winning products to the growing Florida medical cannabis community,” said Bob Groesbeck, Co-CEO of Planet 13. “

[Read More] This Is How Marijuana Stocks May Be Impacted By Donald Trump’s Tariffs

FLUENT Corp.

FLUENT Corp., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. Recently, the company announced it has expanded the Hyer Kind brand to the NYC cannabis market.

Hyer Kind’s expertly crafted, live rosin-infused pre-rolls “Boosters” are now available at all adult-use FLUENT retail stores throughout New York.

[Read More] April 2025 Watchlist: Leading Cannabis Stocks from Canada

Words From The CEO

“We are thrilled to expand access to Hyer Kind products beyond Florida and now into New York,” said Robert Beasley, CEO of FLUENT. “As we grow our brand and product portfolio in New York, we remain committed to aligning our menu selection with Florida, ensuring consistency and familiarity for our patients and customers nationwide.”

The post This Is How The Tariffs Will Impact Marijuana Stocks In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to show strong momentum, with projections estimating the market will reach over $45 billion in 2025. This rapid growth is fueled by expanding legalization and widespread consumer demand. Nearly half of Americans have tried cannabis, and most now live near at least one dispensary. Moreover, the industry supports hundreds of thousands of full-time jobs, making it a major contributor to the U.S. economy. However, recent headlines indicate that federal cannabis reform may be delayed. Lawmakers remain divided, and the White House has not announced any immediate plans to reschedule marijuana. Even so, optimism remains high as more states push for legalization in 2025.

Because cannabis stocks are often volatile, traders should rely on technical analysis to guide their strategies. Chart patterns, support and resistance levels, and moving averages can help identify potential entry points. However, managing risk is equally important. Investors should set stop-loss orders and size positions appropriately. Diversification also reduces exposure to individual stock swings. Staying updated on market news and federal policy developments is crucial. In this evolving sector, success depends on discipline, research, and patience.

As the cannabis sector continues to gain traction, certain U.S.-based companies will stand out in April 2025. Three leading operators—Curaleaf Holdings Inc. (CURLF), Cresco Labs Inc. (CRLBF), and Ayr Wellness Inc. (AYRWF)—are gaining investor attention due to their scale, strategy, and financial strength. Each has carved out a significant share of the U.S. cannabis market and continues to position for long-term growth. Let’s take a closer look at these three top marijuana stocks.

[Read More]  3 Marijuana Stocks That Could Be Top Market Performers

Q2 2025 Cannabis Watchlist: U.S. Stocks With Upside Potential

1. Curaleaf Holdings Inc. (OTC: CURLF)
2. Cresco Labs Inc. (OTC: CRLBF)
3. Ayr Wellness Inc. (OTC: AYRWF)

Curaleaf Holdings Inc. (CURLF)

Curaleaf Holdings Inc. remains one of the largest cannabis operators in the United States. The company operates in 23 states and has more than 130 dispensaries nationwide. Its wide reach allows it to serve both medical and recreational customers across multiple regions. Curaleaf’s largest market presence is in Florida, with dozens of dispensary locations. These locations cater to a fast-growing patient base and benefit from rising cannabis demand in the state. In addition, Curaleaf is expanding internationally, but its U.S. footprint remains its core revenue driver.

The company continues strengthening its brand through new product launches and a focus on customer service. It offers a wide selection of flower, vapes, edibles, and wellness products. Each location is designed to give customers a consistent, informative, and safe shopping experience. Over time, Curaleaf has built strong relationships with patients and adult-use consumers alike. It has also invested heavily in cultivation and production to support long-term growth. Because of its size and reputation, it remains a major player to watch.

In its most recent earnings report, Curaleaf reported revenue of $331.1 million for the fourth quarter of 2024. This marked a 4% decline compared to the prior year’s fourth quarter. However, gross profit was $157.4 million, showing a year-over-year margin improvement. For the full year 2024, revenue totaled $1.34 billion, remaining flat compared to 2023. International revenue rose sharply, increasing by over 70% year-over-year.

The company’s adjusted EBITDA remained stable, supported by cost controls and margin improvements. Despite a small drop in sales, Curaleaf made operational progress that strengthened its profitability. It ended the year with strong liquidity and continues to reduce costs while driving product innovation. Curaleaf’s balance between growth and financial discipline positions it well for 2025.

[Read More] Undervalued U.S. Cannabis Penny Stocks to Add to Your Watchlist

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. is a major vertically integrated cannabis company with operations across several key U.S. states. The company’s retail segment operates under the Sunnyside brand. It currently owns and manages 71 dispensaries across six states. These retail stores focus on consumer education, product accessibility, and a modern shopping experience. Cresco also emphasizes e-commerce and online ordering to streamline customer transactions. Its operations span major markets like Illinois, Pennsylvania, and Ohio.

Cresco is especially known for its strong portfolio of cannabis brands. These include products in the flower, concentrate, edible, and vape categories. The company focuses on brand loyalty and has consistently increased its share in high-volume retail states. Through vertical integration, Cresco controls the entire supply chain. This allows for consistency, efficiency, and better margins. In recent years, Cresco has sharpened its business model to emphasize profitability over expansion.

In its 2024 financial results, Cresco reported a total revenue of $724 million, which was down 6% year-over-year. However, the company improved its gross margin to 52%, up 270 basis points from the previous year. This margin growth highlights successful cost management and efficiency gains. Cresco also reported $132 million in operating cash flow, a 126% increase from 2023. Free cash flow came in at $114 million, showing strong financial discipline.

The company maintained solid liquidity and worked to reduce debt obligations over time. Operating expenses were tightly managed, and capital expenditures were cut significantly. Despite a dip in total revenue, Cresco exited 2024 with improved profitability and cash flow. These results show that the company’s focus on fundamentals is paying off. Heading into 2025, Cresco is positioned for long-term strength in a competitive market.

[Read More]  Top Canadian Cannabis Stocks to Watch in April 2025

Ayr Wellness Inc. (AYRWF)

Ayr Wellness Inc. is a multi-state cannabis operator focused on building strong regional businesses. The company has a presence in seven U.S. states, including major markets like Florida, Massachusetts, Pennsylvania, and New Jersey. It operates more than 60 dispensaries in Florida alone. Ayr Cannabis Dispensary operates these locations and actively serves medical marijuana patients across the state. Florida remains Ayr’s strongest market, where it has developed deep local customer relationships.

The company provides a full range of cannabis products, including flower, concentrates, vapes, and wellness items. Ayr focuses on delivering excellent service and high-quality products. It has invested heavily in cultivation and processing facilities to support vertical integration. The brand experience is personalized and patient-focused, especially in medical markets. With a combination of retail stores and backend infrastructure, Ayr is building long-term value across its operational footprint.

For the fourth quarter of 2024, Ayr reported $114 million in revenue. This was flat compared to the previous quarter and slightly down from the prior year. The company’s adjusted gross margin was 49%, showing consistent cost performance. Adjusted EBITDA for the quarter was $19.1 million, resulting in a margin of 16.7%. These figures reflect disciplined operations and tight expense management.

Ayr finished the year with a cash balance of $35.5 million. Although this was lower than the previous quarter, the company still generated $9.6 million in operating cash flow for the full year. It also continued to streamline operations and exit underperforming markets. The focus remains on core markets, profitability, and operational efficiency. Ayr’s leadership has emphasized sustainable growth heading into 2025.

Best U.S. Marijuana Stocks to Trade This Spring Season

Curaleaf, Cresco Labs, and Ayr Wellness are three standout cannabis stocks for April 2025. Each company operates at scale, manages a strong retail footprint, and is improving its financial discipline. While the broader cannabis market faces regulatory uncertainty, these companies are building solid foundations. Investors watching the sector should consider these names for their proven track records and potential upside as reform evolves

The post Top U.S. Marijuana Stocks to Watch in Q2 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025.

A conference call and audio webcast will also be held on Wednesday, May 7, 2025, at 5:00 p.m. Eastern Time/4:00 p.m. Central Time to discuss the results and answer any questions.

Live conference call: 844-883-3895 (Toll-Free) and 412-317-5797 (International)

Live and archived webcast: https://investors.gtigrows.com

Participants may pre-register for the live conference call any time prior to the start of the call by navigating to https://dpregister.com/sreg/10198223/feced433d0 and entering their contact information. You will then receive a personalized phone number and PIN to dial into the live conference call.

About Green Thumb Industries:
Green Thumb Industries Inc. (“Green Thumb”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE Dispensaries. Headquartered in Chicago, Illinois, Green Thumb has 20 manufacturing facilities, 103 open retail locations and operations across 14 U.S. markets. Established in 2014, Green Thumb employs approximately 4,800 people and serves millions of patients and customers each year. More information is available at www.gtigrows.com.

Investor Contact:
Andy Grossman
EVP, Capital Markets & Investor Relations
InvestorRelations@gtigrows.com
310-622-8257

Media Contact:
GTI Communications
media@gtigrows.com

The post Green Thumb Industries Inc. (GTBIF) to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry has undergone many changes over the last decade. More states have gone legal with only a few left before the entire USA has legalized cannabis. As more companies enter the market, the potential for better growth and more investors becomes evident. Many legal operators in the USA are reporting large amounts of revenue. This sparks the interest of those looking to enter the space without the heavy lifting. This is where looking into marijuana stocks can be a saving grace for those who want to join the cannabis sector.

Although much of the industry is on a downtrend due to various factors surrounding reform and regulations. The future of the industry assuming better reform comes into play could shift the marijuana stocks for the better. So as more people see the long-term with cannabis stocks as the play, this is where strategy comes into the picture. With how low companies are trading, this is where you can find top marijuana stocks to buy and hold till the right time.

Now, as many shareholders know, holding marijuana stocks can be a brutal situation as it’s game up if and when there is volatility associated with the market uncertainty. Still, hopes remain high as the industry as a whole is still progressing and thriving. Below are some marijuana stocks to watch that could see better trading in the future.

Marijuana Stocks To Watch For Better Trading

1. Trulieve Cannabis Corp. (OTC:TCNNF)
2. Green Thumb Industries Inc. (OTC:GTBIF)
3. Planet 13 Holdings Inc. (OTC:PLNH)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries as well as through home delivery.

On March 26th, the company announced the availability of Onward beverages powered by Trulieve in select Shores Liquor locations. Which will be coming soon to ABC Fine Wine & Spirits locations in Florida.

Words From CEO Kim Rivers

“We are excited to expand distribution of Onward beverages in Florida,” said Trulieve’s Chief Executive Officer Kim Rivers. “We look forward to working with both Shores Liquor and ABC Fine Wine & Spirits to educate consumers about this new and exciting option for adult refreshment.”

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States. It operates through two segments, Retail and Consumer Packaged Goods.

In Mid-March the company opened its 6th Ohio location, the RISE dispensary in Whitehall. This is the first RISE Dispensary to open in Ohio since adult-use sales launched in Ohio in August 2024.

[Read More] 3 Marijuana Stocks That Make Better Investments Than The Rest

Words From The Company

“It is an exciting day for Green Thumb in the Buckeye State as we open our sixth RISE Dispensary in Ohio and first location in the Columbus area,” said Green Thumb President Anthony Georgiadis.”

[Read More] Top Canadian Cannabis Stocks to Watch in April 2025

Planet 13 Holdings Inc.,

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

In recent news, the company announced the grand opening of the Port Richey dispensary in the Tampa Bay area.

Words From The CEO

“We are eager to expand our presence in Florida and in the rapid-growth Tampa Bay region with the opening of Planet 13 Port Richey,” said Larry Scheffler, Co-CEO of Planet 13.”

The post Starting The Week With Top Marijuana Stocks To Watch Today appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces today that, further to its press release dated February 3, 2025, Brad Asher’s resignation from his position as Chief Financial Officer of the Company is effective March 23, 2025.

The Board is pleased to announce the appointment of Donna Granato as Interim Chief Financial Officer of the Company, effective immediately. Ms. Granato brings more than 25 years in corporate finance and operations, most recently serving as CFO of Vivvix, a global digital advertising company. Before that she served in high level finance roles at GTT Communications, Shutterstock, Tribune Media, and Omnicom Group.

“We are excited to welcome Donna, whose deep expertise and proven track record make her exceptionally well-suited to lead AYR’s financial organization,” said Steven M. Cohen, Interim CEO of AYR.

About AYR Wellness Inc.
AYR Wellness is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.

AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit www.ayrwellness.com.

Company/Media Contact:
Robert Vanisko
VP, Public Engagement
T: (786) 885-0397
Email: comms@ayrwellness.com

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
T: (786) 885-0397
Email: ir@ayrwellness.com

The post AYR Wellness Inc. (AYRWF) Announces Changes to Management appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), a market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year-ended December 31, 2024.

2024 Business Highlights

Achieved sequential quarterly revenue growth throughout 2024

Reduced operating expenses by over $22.4 million while strengthening operational performance

Successfully launched a new e-commerce platform with significantly enhanced capabilities

Expanded retail distribution, including 847 Walmart stores and now with a presence on Walmart.com, as well as Chewy.com, America’s largest online pet retailer

Introduced new product innovations, including functional mushroom gummies and CBD gel caps

Reduced operating expenses by over $22.4 million while strengthening operational performance

“2024 marked a turning point for Charlotte’s Web operationally as we delivered consecutive quarterly revenue growth, strengthened operations, and positioned the Company for sustained growth in 2025,” said Bill Morachnick, Chief Executive Officer of Charlotte’s Web. “With the successful launch of new product innovations, expanded retail partnerships, and transition underway to in-house manufacturing, we have laid the foundation for further strengthening the business in 2025. We’re particularly excited to announce that we will soon be offering our functional mushroom gummies on Amazon.com, representing our first meaningful presence on Amazon and introducing the Charlotte’s Web brand to millions of potential new customers. This not only diversifies our revenue streams but also reflects our commitment to access, including where consumers increasingly purchase health and wellness products. We are committed to delivering shareholder value through disciplined execution and continued expansion, evolving as a broader botanical wellness leader, beyond CBD.”

“Disciplined expense and cash flow management were top priorities throughout 2024,” added Erika Lind, Chief Financial Officer. “Our omnichannel strategy and operational optimization have been instrumental in navigating a complex regulatory environment while improving our cost structure. We executed significant expense reductions, reduced cash burn, and improved efficiencies across the business. The substantial improvement in our fourth quarter Adjusted EBITDA1 performance reflects the effectiveness of these measures, positioning us to continue reducing cash burn as we approach positive cash flow. We anticipate further improvements in 2025.”

2024 Business Review

Charlotte’s Web made significant strides in 2024, stabilizing its business and advancing strategic initiatives across product innovation, retail expansion, and operational efficiency.

Omnichannel Expansion and E-Commerce Growth
The Company’s new e-commerce platform, launched in mid-2024, improved site performance, enhanced the shopping experience and drove higher customer engagement. Advanced customer tools and marketing automation have increased conversion rates and sales volumes. New retail partnerships were added, including Walmart for topicals and Chewy.com for pet wellness products, further strengthening Charlotte’s Web’s national footprint. The transition toward an omnichannel model allows Charlotte’s Web to leverage direct-to-consumer (DTC), retail, and third-party platforms, streamlining distribution while broadening consumer accessibility.

New Product Innovations
New product innovations and categories included a successful expansion into minor cannabinoid CBN with the launch of Stay Asleep CBN Gummies, demonstrating strong demand for targeted botanical solutions and reinforcing Charlotte’s Web’s position in sleep wellness. In addition, launched in Q4 2024, Charlotte’s Web expanded into botanical wellness beyond CBD with functional mushroom gummies for focus, stress support, and energy.

Operational Efficiencies and Cost Management
Preparation for in-house manufacturing of gummies for full commercial production progressed in Q4 2024, with production ramp-up expected in 2025, improving margins and enhancing speed-to-market for future innovations. Expense reductions initiated in early 2024 materially lowered operating costs by $22.4 million, with similar spending continuing in 2025. The Company ended 2024 with $22.6 million in cash reserves, and the discipline of stringent expense management supports a strategic roadmap toward positive cash flow.

“With deeper retail penetration, new product categories, and improved operational efficiencies, we enter 2025 with momentum,” added Morachnick. “Charlotte’s Web is positioned to lead the next growth phase in botanical wellness while creating lasting value for shareholders.”

DeFloria Milestone
On February 24, 2025, the Company announced that the U.S. Food and Drug Administration (“FDA”) completed its review of the Phase 1 data and Investigational New Drug (“IND”) application submitted by DeFloria, Inc., an entity in which the Company is a stakeholder. The FDA has concluded that DeFloria may now proceed with the Phase 2 clinical trial for its botanical pharmaceutical candidate, AJA001 Oral Solution, a treatment for symptoms of autism spectrum disorder (“ASD”).

DeFloria is a collaboration between Charlotte’s Web, Ajna Biosciences, and British American Tobacco to develop AJA001 as a treatment for irritability associated with autism spectrum disorder. AJA001 employs the Company’s proprietary full-spectrum cannabidiol hemp extract derived from one of its patented cultivars. Charlotte’s Web has rights related to manufacturing for any eventual commercialization of AJA001 as an FDA-regulated botanical drug. Being the manufacturer of this product could represent a substantial long-term revenue opportunity for Charlotte’s Web upon potential FDA approval.

Financial Review

The following table sets forth selected financial information for the periods indicated:

Three months ended

Year ended

December 31,

December 31,

U.S. $ millions, except per share data

2024

2023

2024

2023

Revenue

$ 12.7

$ 15.9

$ 49.7

$ 63.2

Cost of goods sold

$ 7.6

$ 7.0

$ 28.4

$ 27.6

Gross profit

5.1

8.9

21.3

35.6

Selling, general and administrative expenses

10.6

18.6

53.3

75.6

Goodwill and asset impairments

–

0.6

–

0.6

Operating loss

(5.5)

(10.3)

(32.0)

(40.6)

Gain on initial investment in unconsolidated entity

–

–

–

10.7

Change in fair value of financial instruments and other

(0.1)

3.7

0.6

9.3

Other income (expense) , net

2.2

(1.4)

1.6

(2.7)

Income tax expense

–

(0.5)

–

(0.5)

Net loss

$ (3.4)

$ (8.5)

$ (29.8)

$ (23.8)

EPS basic and diluted

$ (0.02)

$ (0.06)

$ (0.19)

$ (0.16)

Adjusted EBITDA

$ 0.3

$ (6.5)

$ (12.6)

$ (22.7)

Assets:

Dec 31, 2024

Dec 31, 2023

Cash and cash equivalents

$ 22.6

$ 47.8

Total assets

$ 113.4

$ 152.5

Liabilities:

Long-term liabilities

$ 70.4

$ 73.3

Total liabilities

$ 86.4

$ 97.0

Fourth Quarter 2024 Financial Review

Consolidated net revenue for the fourth quarter ended December 31, 2024, was $12.7 million, compared to $15.9 million in the fourth quarter of 2023. Revenue increased modestly on a quarter-over-quarter basis versus Q3 2024 revenue of $12.6 million.

Quarterly revenue trend for 2024:

Q1

Q2

Q3

Q4

U.S. $ millions

2024

2024

2024

2024

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

In the fourth quarter, some retailers were negatively impacted by state regulations restricting the sale of certain CBD products, despite meeting federal requirements. However, e-commerce revenue increased quarter-over-quarter following the launch of the Company’s new e-commerce platform.

Gross Profit in Q4 2024 was $5.1 million, or 40.2% of revenue, compared to Gross Profit of $8.9 million, or 56.0% of revenue, in Q4 2023. The reduction in gross margin reflected holiday promotional investments, temporary shipping inefficiencies, and reduced fixed cost absorption on lower-than-expected revenue. The Company models gross margin to return above 50% in 2025.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $10.6 million, a 43% improvement from $18.6 million in Q4 2023. Stringent expense controls were implemented during the year to better align with current revenue levels.

Net loss for the fourth quarter of 2024 was $3.4 million, or ($0.02) per share basic and diluted, compared to a net loss of $8.5 million, or ($0.06) per share basic and diluted, for the fourth quarter of 2023.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported positive Adjusted EBITDA1 for the fourth quarter of 2024 of $0.3 million, a $6.8 million improvement compared to negative Adjusted EBITDA of $6.5 million in the fourth quarter of 2023.

Fiscal Year 2024 Financial Review
On a year-over-year basis, consolidated net revenue for the twelve months ended December 31, 2024, was $49.7 million, a decrease of 21.4% from $63.2 million in 2023. Revenue was negatively impacted by inflationary impacts on consumer spending and reduced retailer shelf allocations to the CBD category. The Company adopted a new e-commerce platform mid-year that has resulted in improving marketing, customer management, and sales volumes.

Gross profit for the year ended December 31, 2024, was $21.3 million, compared to $35.6 million for the year ended December 31, 2023. Gross profit was negatively impacted by a $4.1 million increase in inventory provision for 2024 due to the revaluation of aged hemp based on current market conditions. The increase was partially offset by lower inventory expenses and other variable costs associated with lower revenue in 2024. Gross profit before inventory provision was $25.4 million, or 51.1%, and $36.6 million, or 58.0%, in 2024 and 2023, respectively.

Total SG&A expense for 2024 was $53.3 million, compared to $75.6 million in the prior year. The $22.4 million or 29.6% decrease resulted from multiple actions taken in 2024 to reduce operating expenses and better align SG&A against the lower revenue levels, including workforce and insurance program adjustments, contract reviews and negotiations, and software optimizations. Additionally, in 2024, the Company amended its MLB Promotional Rights Agreement, resulting in a decrease in amortization and media expense related to MLB assets of approximately $4.9 million compared to 2023.

An operating loss of $32 million in 2024 improved 21.2% from an operating loss of $40.6 million in 2023. Net loss for 2024 was $29.8 million, or $(0.19) per share, basic and diluted, compared to a net loss of $23.8 million, or $(0.16) per share, basic and diluted, in 2023. The lower net loss in 2023 was due to a combined net gain of $20.0 million in that year in the fair value of the Company’s debt derivative and from its investment in DeFloria.

Excluding depreciation, amortization, and interest, the EBITDA1 loss for 2024 was $17.6 million, as compared to an EBITDA loss of $6.3 million for 2023. 2024 included a higher inventory provision than 2023, which included the combined net gain of $20.0 million in fair value of the Company’s debt derivative and from its investment in DeFloria. Excluding these items, the Adjusted EBITDA1 loss was $12.6 million for 2024, as compared to the Adjusted EBITDA loss of $22.7 million for 2023.

Balance Sheet and Cash Flow
Net cash used for operations in the fourth quarter of 2024 was $1.8 million. Net cash used for operations in the year ended December 31, 2024, was $21.2 million, including cash paid to MLB for license and media rights assets of $5 million. Capital expenditures of $3.9 million were primarily used for the in-house production of topical and gummy projects.

The Company’s cash and working capital as of December 31, 2024, were $22.6 million and $31.1 million, respectively, compared to $47.8 million and $54.5 million as of December 31, 2023, respectively.

“With reduced cash burn, having cash reserves exceeding $22 million provides the runway for 2025 growth and beyond,” said Mrs. Lind. “In-house production will increase in 2025, and continued expense discipline is key to stabilizing our financial position.”

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s audited consolidated financial statements and accompanying notes for the three and twelve-month periods ended December 31, 2024, and 2023, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-K filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

Analyst Conference Call
Management will host a conference call to discuss the Company’s 2024 fourth quarter and year-end results at 11:00 A.M. ET on March 19, 2025.

There are three ways to join the call:

Register and enter your phone number at https://emportal.ink/3EK35Bz to receive an instant automated call back, or

Dial 1-646-357-8785 or 1-800-836-8184 approximately 10 minutes before the conference call, or

Listen to the live webcast online.

Earnings Call Replay
A recording of the call will be available through March 26, 2025. To listen to a replay of the earnings call, please dial 1- 646-517-4150 or 1-888-660-6345 and provide conference replay ID 90317#. A webcast of the call will also be accessible through the investor relations section of the Company’s website for an extended period of time.

Subscribe to Charlotte’s Web investor news.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is the market leader in innovative hemp extract wellness products that include Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD certified NSF for Sport®. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

Charlotte’s Web is the official CBD of Major League Baseball©.

© Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information
Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume ad gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the impact of the Company’s partnership with the MLB and PLL on the Company’s exposure and sales; the Company’s ability to increase online traffic and demographic exposure through new products and marketing; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available on www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars, except share and per share amounts)

December 31,

2024

2023

ASSETS

Current assets:

Cash and cash equivalents

$ 22,618

$ 47,820

Accounts receivable, net

1,263

1,950

Inventories, net

18,907

21,538

Prepaid expenses and other current assets

4,194

6,864

Total current assets

46,982

78,172

Property and equipment, net

26,337

27,513

License and media rights

13,691

17,070

Operating lease right-of-use assets, net

12,876

14,601

Investment in unconsolidated entity

10,800

11,000

SBH purchase option and other derivative assets

1,075

2,602

Intangible assets, net

1,049

887

Other long-term assets

632

703

Total assets

$ 113,442

$ 152,548

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,426

$ 2,860

Accrued and other current liabilities

5,246

8,682

Lease obligations – current

2,055

2,252

License and media rights payable – current

5,209

9,852

Total current liabilities

15,936

23,646

Convertible debenture

43,631

42,528

Lease obligations

13,652

15,655

License and media rights payable

11,809

11,338

Derivative and other long-term liabilities

1,327

3,823

Total liabilities

86,355

96,990

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and 154,332,366 shares issued and outstanding as of December 31, 2024 and 2023, respectively

1

1

Additional paid-in capital

328,655

327,280

Accumulated deficit

(301,569)

(271,723)

Total shareholders’ equity

27,087

55,558

Total liabilities and shareholders’ equity

$ 113,442

$ 152,548

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands of U.S. dollars, except share and per share amounts)

Year Ended December 31,

2024

2023

Revenue

$ 49,667

$ 63,155

Cost of goods sold

28,407

27,589

Gross profit

21,260

35,566

Selling, general and administrative expenses

53,247

75,630

Asset impairment

—

548

Operating loss

(31,987)

(40,612)

Gain on initial investment in unconsolidated entity

—

10,700

Change in fair value of financial instruments

615

9,339

Other income (expense), net

1,565

(2,694)

Loss before provision for income taxes

$ (29,807)

$ (23,267)

Income tax expense

(39)

(529)

Net loss

$ (29,846)

$ (23,796)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.19)

$ (0.16)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2022

152,135,026

$ 1

$ 325,431

$ (247,927)

$ 77,505

Common shares issued upon vesting of restricted share units, net of withholdings

2,197,340

—

(251)

—

(251)

Share-based compensation

—

—

2,100

—

2,100

Net loss

—

—

—

(23,796)

(23,796)

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units, net of withholding

3,677,175

—

(145)

—

(145)

Share-based compensation

—

—

1,520

—

1,520

Net loss

—

—

—

(29,846)

(29,846)

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Year Ended December 31,

2024

2023

Cash flows from operating activities:

Net loss

$ (29,846)

$ (23,796)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

9,979

15,160

Change in fair value of financial instruments

(615)

(9,339)

Gain on initial investment in unconsolidated entity

—

(10,700)

Convertible debenture and other accrued interest

3,724

3,857

Gain on foreign currency transaction

(3,631)

1,142

Share-based compensation

1,520

2,100

Changes in right-of-use assets

1,771

1,918

Allowance for credit losses

140

1,240

Inventory provision

4,154

1,039

Asset impairment

—

548

Other

611

3,313

Changes in operating assets and liabilities:

Accounts receivable, net

361

(809)

Inventories, net

(1,520)

4,376

Prepaid expenses and other current assets

1,332

85

Operating lease obligations

(2,247)

(2,304)

Accounts payable, accrued and other liabilities

(1,664)

151

License and media rights payable

(5,000)

(8,000)

Income tax and other receivable

—

4,261

Other operating assets and liabilities, net

(330)

372

Net cash used in operating activities

(21,261)

(15,386)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(3,851)

(3,691)

Proceeds from sale of assets

55

185

Net cash provided by/(used in) investing activities

(3,796)

(3,506)

Cash flows from financing activities:

Other financing activities

(145)

(251)

Net cash used in financing activities

(145)

(251)

Net decrease in cash and cash equivalents

(25,202)

(19,143)

Cash and cash equivalents —beginning of year

47,820

66,963

Cash and cash equivalents —end of year

$ 22,618

$ 47,820

Non-cash activities:

Non-cash issuance of note receivable

—

(170)

Non-cash purchases of property and equipment and intangibles

(3)

(233)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financials measures do not have a standardized meaning prescribed under U.S. GAAP and therefore may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

(1)

EBITDA and Adjusted EBITDA are non-GAAP financial measures with reconciliations provided in the table below:

Adjusted EBITDA for the three and twelve months ended December 31, 2024, and 2023 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended

Year Ended

December 31,

December 31,

(unaudited)

(audited)

U.S. $ Thousands

2024

2023

2024

2023

Net loss

$ (3,371)

$ (8,589)

$ (29,846)

$ (23,796)

Depreciation of property and equipment and amortization of intangibles

2,473

3,650

9,979

15,160

Interest (income) expense

643

350

2,201

1,786

Income tax expense

(22)

529

39

529

EBITDA

(277)

(4,060)

(17,627)

(6,321)

Stock Comp

223

454

1,520

2,100

Mark-to-market financial instruments

86

(3,752)

(615)

(9,339)

Impairment

–

548

–

548

Inventory Provision

228

309

4,154

1,039

Initial gain on investment in DeFloria

–

–

–

(10,700)

Adjusted EBITDA

$ 260

$ (6,501)

$ (12,568)

$ (22,673)

View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-reports-2024-fourth-quarter-and-year-end-financial-results-302405400.html

SOURCE Charlotte’s Web Holdings, Inc.

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

There are several outlooks on how investors view marijuana stocks. This perception is based on various information and market behavior over the last several years. For the most part, a bulk of cannabis stock investors are frustrated. This comes from inconsistent trading patterns that have led to more downtrends. Much of this stems from issues with passing federal reform and establishing more efficient regulations in legal regions around the USA.

Right now, non-MSO legal operators in the US are having issues with competing due to high taxes and licensing fees. The smaller players are in a space known as small batch cultivators, farmers who handle the plant with care. Quality over quantity is how they run their ship, and for true cannabis customers, it’s the only way to go. Now, that is not to say that larger players like Curaleaf or Planet 13 Holdings are not feeling the struggle as well.

As a whole, the cannabis industry is still improving, but fear has been a huge hindrance in seeing stronger market action. With all the politics getting in the way, it has created aggressive, volatile action. Yet companies as a whole are profiting and continuing progress. Hopefully, this will once again transcend into better, more stable market action. Below are a few marijuana stocks to watch in the stock market this week.

Marijuana Stocks To Watch Today

1. Verano Holdings Corp. (OTC:VRNOF)
2. Jushi Holdings Inc. (OTC:JUSH)

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States.

The company announced the launch of a wave of new product innovations across the fastest-growing categories in key markets.

Words From The Company

“As consumer appetite for differentiated cannabis products increases, particularly in the vape and pre-roll categories, we are excited to unleash a wave of innovation across our Savvy and (the) Essence portfolios featuring unique styles, experiences and engagement,” said David Spreckman, Verano Chief Marketing Officer.“

[Read More] 3 Marijuana Stocks To Watch This Month As Trading May Begin To Build

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. On March 6th the company reported its Q4 and full year 2024 financial results.

[Read More] 3 Marijuana Stocks For Investors To Get Excited About

Highlights And Key Mentions

• Total revenue of $65.9 million
• Gross profit and gross profit margin of $25.4 million and 38.6%, respectively,
• Net loss of $12.5 million
• Adjusted EBITDA1 and Adjusted EBITDA1 margin of $8.0 million and 12.2%, respectively
• Cash, cash equivalents and restricted cash were $21.3 million as of quarter end
• Net cash flows provided by operations of $7.2 million

The post Top Marijuana Stocks For Investors In The Cannabis Space appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..